Response to Comment on "Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin"
回复“药物转运蛋白 OCT2 的表观遗传激活使肾细胞癌对奥沙利铂敏感”的评论
期刊:Science Translational Medicine
影响因子:15.8
doi:10.1126/scitranslmed.aam6298
Xiaoli Zheng, Yanqing Liu, Qinqin Yu, Hua Wang, Fuqing Tan, Qianying Zhu, Lingmin Yuan, Huidi Jiang, Su Zeng, Lushan Yu
